🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy of aprepitant in pre...
Status
Completed
Location
Washington University School of Medicine
Start Date
2005-10
Trial ID
NCT00314743
Treatments Being Tested
The current recommended guideline for patients receiving moderately emetoge...
Status
Completed
Location
Samsung Medical Center
Start Date
2010-05
Trial ID
NCT01012336
Treatments Being Tested
Compared With Fosaprepitant dimeglumine for Injection and Palonosetron Hydr...
Status
Completed
Location
Zhe jiangCancer Hospital
Start Date
2025-01-03
Trial ID
NCT07081256
This randomized phase III trial studies how well olanzapine with or without...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-11-20
Trial ID
NCT03578081
This pragmatic trial addresses the clinical gap through the generation of e...
Status
Unknown
Location
CHU Avicenne
Start Date
2018-09-19
Trial ID
NCT03831633
Treatments Being Tested
This study will assess the efficacy of a single dose of intravenous (IV) fo...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-25
Trial ID
NCT01405924
Treatments Being Tested
RATIONALE: Antiemetic drugs, such as aprepitant, ondansetron, and dexametha...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2004-05
Trial ID
NCT00248547
Treatments Being Tested
Dysmenorrhea is characterized as excruciating menstrual cramps of uterine o...
Status
Completed
Location
Prof. Dr. Riffat Mehboob
Start Date
2024-03-15
Trial ID
NCT06317064
Treatments Being Tested
To determine the best method to prevent CINV caused by TC regimen in patien...
Status
Completed
Location
Dengfeng Wang
Start Date
2024-05-31
Trial ID
NCT06007586
Treatments Being Tested
This study will demonstrate and confirm the efficacy and safety of MK0869 f...
Status
Completed
Location
Multiple Locations
Start Date
2009-08-25
Trial ID
NCT00952341
Treatments Being Tested